These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 22014570)

  • 61. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.
    Liu M; Dai B; Kang SH; Ban K; Huang FJ; Lang FF; Aldape KD; Xie TX; Pelloski CE; Xie K; Sawaya R; Huang S
    Cancer Res; 2006 Apr; 66(7):3593-602. PubMed ID: 16585184
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
    Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FoxM1 regulates re-annealing of endothelial adherens junctions through transcriptional control of beta-catenin expression.
    Mirza MK; Sun Y; Zhao YD; Potula HH; Frey RS; Vogel SM; Malik AB; Zhao YY
    J Exp Med; 2010 Aug; 207(8):1675-85. PubMed ID: 20660612
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling.
    Wu X; Tu X; Joeng KS; Hilton MJ; Williams DA; Long F
    Cell; 2008 Apr; 133(2):340-53. PubMed ID: 18423204
    [TBL] [Abstract][Full Text] [Related]  

  • 66. miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt/β-catenin signaling pathway.
    Tian W; Zhu W; Jiang J
    Cell Biol Int; 2020 May; 44(5):1156-1167. PubMed ID: 32009256
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells.
    Dai B; Kang SH; Gong W; Liu M; Aldape KD; Sawaya R; Huang S
    Oncogene; 2007 Sep; 26(42):6212-9. PubMed ID: 17404569
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas.
    Pulvirenti T; Van Der Heijden M; Droms LA; Huse JT; Tabar V; Hall A
    Cancer Res; 2011 Dec; 71(23):7280-90. PubMed ID: 21990322
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in glioma.
    Verma BK; Kondaiah P
    J Neurooncol; 2020 Sep; 149(2):209-217. PubMed ID: 32803659
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A lignan induces lysosomal dependent degradation of FoxM1 protein to suppress β-catenin nuclear translocation.
    Dong GZ; Jeong JH; Lee YI; Han YE; Shin JS; Kim YJ; Jeon R; Kim YH; Park TJ; Kim KI; Ryu JH
    Sci Rep; 2017 Apr; 7():45951. PubMed ID: 28378765
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.
    Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J
    Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
    Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
    Kang DW; Min do S
    PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
    Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.
    Yang YF; Pan YH; Cao Y; Fu J; Yang X; Zhang MF; Tian QH
    Oncotarget; 2017 Jul; 8(29):47195-47205. PubMed ID: 28525379
    [TBL] [Abstract][Full Text] [Related]  

  • 76. AMOTL2‑knockdown promotes the proliferation, migration and invasion of glioma by regulating β‑catenin nuclear localization.
    Chen X; Lu Y; Guo G; Zhang Y; Sun Y; Guo L; Li R; Nan Y; Yang X; Dong J; Jin X; Huang Q
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036399
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PAX3 Promotes Proliferation of Human Glioma Cells by WNT/β-Catenin Signaling Pathways.
    Liang X; Dong Z; Bin W; Dekang N; Xuhang Z; Shuyuan Z; Liwen L; Kai J; Caixing S
    J Mol Neurosci; 2019 May; 68(1):66-77. PubMed ID: 30826985
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deletion of Forkhead Box M1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells.
    Chen W; Yuan K; Tao ZZ; Xiao BK
    Asian Pac J Cancer Prev; 2011; 12(7):1785-8. PubMed ID: 22126565
    [TBL] [Abstract][Full Text] [Related]  

  • 79. miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.
    Guo M; Zhang X; Wang G; Sun J; Jiang Z; Khadarian K; Yu S; Zhao Y; Xie C; Zhang K; Zhu M; Shen H; Lin Z; Jiang C; Shen J; Zheng Y
    Cancer Lett; 2015 Apr; 360(1):76-86. PubMed ID: 25681036
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas.
    Vallée A; Guillevin R; Vallée JN
    Rev Neurosci; 2018 Jan; 29(1):71-91. PubMed ID: 28822229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.